{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:39:29Z","timestamp":1791005969797,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T00:00:00Z","timestamp":1619222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T00:00:00Z","timestamp":1619222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s11926-021-00995-y","type":"journal-article","created":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T07:11:32Z","timestamp":1619334692000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Recent Updates in the Immunopathology of Type 3 Immunity-Mediated Enthesitis"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4258-1603","authenticated-orcid":false,"given":"Akihiro","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3210-4771","authenticated-orcid":false,"given":"Nigil","family":"Haroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,24]]},"reference":[{"key":"995_CR1","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nrrheum.2017.188","volume":"13","author":"G Schett","year":"2017","unstructured":"Schett G, Lories RJ, D\u2019Agostino M-A, Elewaut D, Kirkham B, Soriano ER, et al. Enthesitis: from pathophysiology to treatment. Nat Rev Rheumatol. 2017;13:731\u201341.","journal-title":"Nat Rev Rheumatol"},{"key":"995_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1302\/2058-5241.1.000049","volume":"1","author":"A Vaquero-Picado","year":"2016","unstructured":"Vaquero-Picado A, Barco R, Antu\u00f1a SA. Lateral epicondylitis of the elbow. EFORT Open Rev. 2016;1:391\u20137.","journal-title":"EFORT Open Rev"},{"key":"995_CR3","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1002\/art.20566","volume":"50","author":"M Benjamin","year":"2004","unstructured":"Benjamin M, Moriggl B, Brenner E, Emery P, McGonagle D, Redman S. The \u201centhesis organ\u201d concept: why enthesopathies may not present as focal insertional disorders. Arthritis Rheum. 2004;50:3306\u201313.","journal-title":"Arthritis Rheum"},{"key":"995_CR4","doi-asserted-by":"publisher","unstructured":"Watad A, Rowe H, Russell T, et al (2020) Normal human enthesis harbours conventional CD4+ and CD8+ T cells with regulatory features and inducible IL-17A and TNF expression. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217309. This study shows that conventional CD4+ and CD8+ T cells exist in human anxial entheses and have an ability to produce IL-17A and TNF.","DOI":"10.1136\/annrheumdis-2020-217309"},{"key":"995_CR5","doi-asserted-by":"publisher","first-page":"1559 LP","DOI":"10.1136\/annrheumdis-2019-215210","volume":"78","author":"RJ Cuthbert","year":"2019","unstructured":"Cuthbert RJ, Watad A, Fragkakis EM, et al. Evidence that tissue resident human enthesis \u03b3\u03b4T-cells can produce IL-17A independently of IL-23R transcript expression. Ann Rheum Dis. 2019;78:1559 LP\u20131565 This study provides the first evidence of IL-17 producing \u03b3\u03b4 T cells independent of IL-23 in human axial entheses, which may be the reason for the ineffectiveness of IL-23 monoclonal antibodies in patients with ankylosing spondylitis.","journal-title":"Ann Rheum Dis"},{"key":"995_CR6","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1002\/art.40150","volume":"69","author":"RJ Cuthbert","year":"2017","unstructured":"Cuthbert RJ, Fragkakis EM, Dunsmuir R, Li Z, Coles M, Marzo-Ortega H, et al. Brief report: group 3 innate lymphoid cells in human enthesis. Arthritis Rheumatol (HobokenNJ). 2017;69:1816\u201322.","journal-title":"Arthritis Rheumatol (HobokenNJ)"},{"key":"995_CR7","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1136\/annrheumdis-2018-214944","volume":"78","author":"C Bridgewood","year":"2019","unstructured":"Bridgewood C, Watad A, Russell T, et al. Identification of myeloid cells in the human enthesis as the main source of local IL-23 production. Ann Rheum Dis. 2019;78:929\u201333 This study demonstrates that IL-23 is produced by CD14+ myeloid cells in human axial entheses, which highlights the importance of locally produced IL-23 in the pathogenesis of axial spondyloarthritis.","journal-title":"Ann Rheum Dis"},{"key":"995_CR8","doi-asserted-by":"publisher","first-page":"101491","DOI":"10.1016\/j.berh.2020.101491","volume":"33","author":"A Nakamura","year":"2019","unstructured":"Nakamura A, Talukdar A, Nakamura S, Pathan E, Haroon N. Bone formation in axial spondyloarthritis: is disease modification possible? Best Pract Res Clin Rheumatol. 2019;33:101491.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"995_CR9","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1136\/annrheumdis-2013-203643","volume":"73","author":"P Jacques","year":"2014","unstructured":"Jacques P, Lambrecht S, Verheugen E, et al. Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells. Ann Rheum Dis. 2014;73:437\u201345.","journal-title":"Ann Rheum Dis"},{"key":"995_CR10","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1136\/annrheumdis-2018-214627","volume":"78","author":"I Cambre","year":"2019","unstructured":"Cambre I, Gaublomme D, Schryvers N, Lambrecht S, Lories R, Venken K, et al. Running promotes chronicity of arthritis by local modulation of complement activators and impairing T regulatory feedback loops. Ann Rheum Dis. 2019;78:787\u201395.","journal-title":"Ann Rheum Dis"},{"key":"995_CR11","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1136\/annrheumdis-2012-201370","volume":"71","author":"F Kroon","year":"2012","unstructured":"Kroon F, Landew\u00e9 R, Dougados M, van der Heijde D. Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis. Ann Rheum Dis. 2012;71:1623\u20139.","journal-title":"Ann Rheum Dis"},{"key":"995_CR12","doi-asserted-by":"publisher","first-page":"ii38","DOI":"10.1093\/rheumatology\/kew349","volume":"55","author":"J Sieper","year":"2016","unstructured":"Sieper J. New treatment targets for axial spondyloarthritis. Rheumatology (Oxford). 2016;55:ii38\u201342.","journal-title":"Rheumatology (Oxford)"},{"key":"995_CR13","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nm.2817","volume":"18","author":"JP Sherlock","year":"2012","unstructured":"Sherlock JP, Joyce-Shaikh B, Turner SP, et al. IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t+ CD3+CD4-CD8- entheseal resident T cells. Nat Med. 2012;18:1069\u201376.","journal-title":"Nat Med"},{"key":"995_CR14","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1136\/annrheumdis-2018-213328","volume":"77","author":"D Baeten","year":"2018","unstructured":"Baeten D, \u00d8stergaard M, Wei JC-C, et al. Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study. Ann Rheum Dis. 2018;77:1295\u2013302.","journal-title":"Ann Rheum Dis"},{"key":"995_CR15","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(11)60071-8","volume":"377","author":"M Dougados","year":"2011","unstructured":"Dougados M, Baeten D. Spondyloarthritis. Lancet (London, England). 2011;377:2127\u201337.","journal-title":"Lancet (London, England)"},{"key":"995_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1136\/ard.30.3.213","volume":"30","author":"J Ball","year":"1971","unstructured":"Ball J. Enthesopathy of rheumatoid and ankylosing spondylitis. Ann Rheum Dis. 1971;30:213\u201323.","journal-title":"Ann Rheum Dis"},{"key":"995_CR17","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S0140-6736(97)12004-9","volume":"352","author":"D McGonagle","year":"1998","unstructured":"McGonagle D, Gibbon W, Emery P. Classification of inflammatory arthritis by enthesitis. Lancet (London, England). 1998;352:1137\u201340.","journal-title":"Lancet (London, England)"},{"key":"995_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1136\/annrheumdis-2014-205461","volume":"75","author":"M Haroon","year":"2016","unstructured":"Haroon M, Winchester R, Giles JT, Heffernan E, FitzGerald O. Certain class I HLA alleles and haplotypes implicated in susceptibility play a role in determining specific features of the psoriatic arthritis phenotype. Ann Rheum Dis. 2016;75:155\u201362.","journal-title":"Ann Rheum Dis"},{"key":"995_CR19","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1136\/annrheumdis-2017-212681","volume":"77","author":"I Tinazzi","year":"2018","unstructured":"Tinazzi I, McGonagle D, Aydin SZ, Chessa D, Marchetta A, Macchioni P. \u201cDeep Koebner\u201d phenomenon of the flexor tendon-associated accessory pulleys as a novel factor in tenosynovitis and dactylitis in psoriatic arthritis. Ann Rheum Dis. 2018;77:922\u20135.","journal-title":"Ann Rheum Dis"},{"key":"995_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/BOR.0000000000000569","volume":"31","author":"E Gracey","year":"2019","unstructured":"Gracey E, Dumas E, Yerushalmi M, Qaiyum Z, Inman RD, Elewaut D. The ties that bind: skin, gut and spondyloarthritis. Curr Opin Rheumatol. 2019;31:62\u20139.","journal-title":"Curr Opin Rheumatol"},{"key":"995_CR21","first-page":"89","volume":"149","author":"M Benjamin","year":"1986","unstructured":"Benjamin M, Evans EJ, Copp L. The histology of tendon attachments to bone in man. J Anat. 1986;149:89\u2013100.","journal-title":"J Anat"},{"key":"995_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s004290000107","volume":"202","author":"T Hems","year":"2000","unstructured":"Hems T, Tillmann B. Tendon entheses of the human masticatory muscles. Anat Embryol (Berl). 2000;202:201\u20138.","journal-title":"Anat Embryol (Berl)"},{"key":"995_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3899\/jrheum.120233","volume":"89","author":"D McGonagle","year":"2012","unstructured":"McGonagle D, Aydin SZ, Tan AL. The synovio-entheseal complex and its role in tendon and capsular associated inflammation. J Rheumatol Suppl. 2012;89:11\u20134.","journal-title":"J Rheumatol Suppl"},{"key":"995_CR24","doi-asserted-by":"publisher","unstructured":"Gracey E, Hromadova D, Lim M, et al. TYK2 inhibition reduces type 3 immunity and modifies disease progression in murine spondyloarthritis. J Clin Invest. 2020. https:\/\/doi.org\/10.1172\/JCI126567.","DOI":"10.1172\/JCI126567"},{"key":"995_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11926-019-0856-3","volume":"21","author":"SJ Pedersen","year":"2019","unstructured":"Pedersen SJ, Maksymowych WP. The pathogenesis of ankylosing spondylitis: an update. Curr Rheumatol Rep. 2019;21:58.","journal-title":"Curr Rheumatol Rep"},{"key":"995_CR26","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/ng.2667","volume":"45","author":"A Cortes","year":"2013","unstructured":"Cortes A, Hadler J, Pointon JP, et al. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet. 2013;45:730\u20138.","journal-title":"Nat Genet"},{"key":"995_CR27","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1002\/art.39732","volume":"68","author":"A Reinhardt","year":"2016","unstructured":"Reinhardt A, Yevsa T, Worbs T, Lienenklaus S, Sandrock I, Oberd\u00f6rfer L, et al. Interleukin-23-dependent \u03b3\/\u03b4 T cells produce interleukin-17 and accumulate in the enthesis, aortic valve, and ciliary body in mice. Arthritis Rheumatol (HobokenNJ). 2016;68:2476\u201386.","journal-title":"Arthritis Rheumatol (HobokenNJ)"},{"key":"995_CR28","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/nm.2749","volume":"18","author":"T Shichita","year":"2012","unstructured":"Shichita T, Hasegawa E, Kimura A, et al. Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain. Nat Med. 2012;18:911\u20137.","journal-title":"Nat Med"},{"key":"995_CR29","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1074\/jbc.M207577200","volume":"278","author":"S Aggarwal","year":"2003","unstructured":"Aggarwal S, Ghilardi N, Xie M-H, de Sauvage FJ, Gurney AL. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem. 2003;278:1910\u20134.","journal-title":"J Biol Chem"},{"key":"995_CR30","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/ni1254","volume":"6","author":"LE Harrington","year":"2005","unstructured":"Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6:1123\u201332.","journal-title":"Nat Immunol"},{"key":"995_CR31","doi-asserted-by":"publisher","first-page":"19402","DOI":"10.1073\/pnas.1008247107","volume":"107","author":"D Valmori","year":"2010","unstructured":"Valmori D, Raffin C, Raimbaud I, Ayyoub M. Human ROR\u03b3t+ TH17 cells preferentially differentiate from naive FOXP3+Treg in the presence of lineage-specific polarizing factors. Proc Natl Acad Sci U S A. 2010;107:19402\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"995_CR32","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/ni.1613","volume":"9","author":"E Volpe","year":"2008","unstructured":"Volpe E, Servant N, Zollinger R, Bogiatzi SI, Hup\u00e9 P, Barillot E, et al. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol. 2008;9:650\u20137.","journal-title":"Nat Immunol"},{"key":"995_CR33","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jdermsci.2009.01.003","volume":"54","author":"N Yawalkar","year":"2009","unstructured":"Yawalkar N, Tscharner GG, Hunger RE, Hassan AS. Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis. J Dermatol Sci. 2009;54:99\u2013105.","journal-title":"J Dermatol Sci"},{"key":"995_CR34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.immuni.2006.05.017","volume":"25","author":"HH Uhlig","year":"2006","unstructured":"Uhlig HH, McKenzie BS, Hue S, et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity. 2006;25:309\u201318.","journal-title":"Immunity"},{"key":"995_CR35","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1136\/annrheumdis-2020-217163","volume":"79","author":"A Kerschbaumer","year":"2020","unstructured":"Kerschbaumer A, Smolen JS, Dougados M, de Wit M, Primdahl J, McInnes I, et al. Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritis. Ann Rheum Dis. 2020;79:778\u201386.","journal-title":"Ann Rheum Dis"},{"key":"995_CR36","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S2468-1253(18)30233-4","volume":"3","author":"BG Feagan","year":"2018","unstructured":"Feagan BG, Pan\u00e9s J, Ferrante M, et al. Risankizumab in patients with moderate to severe Crohn\u2019s disease: an open-label extension study. Lancet Gastroenterol Hepatol. 2018;3:671\u201380.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"995_CR37","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/S0140-6736(13)60594-2","volume":"382","author":"IB McInnes","year":"2013","unstructured":"McInnes IB, Kavanaugh A, Gottlieb AB, et al. Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial. Lancet (London, England). 2013;382:780\u20139.","journal-title":"Lancet (London, England)"},{"key":"995_CR38","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1136\/annrheumdis-2018-214381","volume":"78","author":"LM Rehaume","year":"2019","unstructured":"Rehaume LM, Matigian N, Mehdi AM, Lachner N, Bowerman KL, Daly J, et al. IL-23 favours outgrowth of spondyloarthritis-associated pathobionts and suppresses host support for homeostatic microbiota. Ann Rheum Dis. 2019;78:494\u2013503.","journal-title":"Ann Rheum Dis"},{"key":"995_CR39","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/art.24389","volume":"60","author":"F Ciccia","year":"2009","unstructured":"Ciccia F, Bombardieri M, Principato A, et al. Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Arthritis Rheum. 2009;60:955\u201365.","journal-title":"Arthritis Rheum"},{"key":"995_CR40","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1136\/annrheumdis-2012-202925","volume":"73","author":"F Ciccia","year":"2014","unstructured":"Ciccia F, Accardo-Palumbo A, Rizzo A, Guggino G, Raimondo S, Giardina A, et al. Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation. Ann Rheum Dis. 2014;73:1566\u201374.","journal-title":"Ann Rheum Dis"},{"key":"995_CR41","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/art.40728","volume":"71","author":"A Deodhar","year":"2019","unstructured":"Deodhar A, Gensler LS, Sieper J, et al. Three multicenter, randomized, double-blind, placebo-controlled studies evaluating the efficacy and safety of ustekinumab in axial spondyloarthritis. Arthritis Rheumatol (Hoboken, NJ). 2019;71:258\u201370.","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"995_CR42","first-page":"369","volume":"22","author":"Y Yoshiga","year":"2008","unstructured":"Yoshiga Y, Goto D, Segawa S, Ohnishi Y, Matsumoto I, Ito S, et al. Invariant NKT cells produce IL-17 through IL-23-dependent and -independent pathways with potential modulation of Th17 response in collagen-induced arthritis. Int J Mol Med. 2008;22:369\u201374.","journal-title":"Int J Mol Med"},{"key":"995_CR43","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1136\/annrheumdis-2015-208902","volume":"75","author":"E Gracey","year":"2016","unstructured":"Gracey E, Qaiyum Z, Almaghlouth I, et al. IL-7 primes IL-17 in mucosal-associated invariant T (MAIT) cells, which contribute to the Th17-axis in ankylosing spondylitis. Ann Rheum Dis. 2016;75:2124\u201332.","journal-title":"Ann Rheum Dis"},{"key":"995_CR44","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/art.38638","volume":"66","author":"H Benham","year":"2014","unstructured":"Benham H, Rehaume LM, Hasnain SZ, et al. Interleukin-23 mediates the intestinal response to microbial \u03b2-1,3-glucan and the development of spondyloarthritis pathology in SKG mice. Arthritis Rheumatol (Hoboken NJ). 2014;66:1755\u201367.","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"key":"995_CR45","first-page":"supple10","volume":"72","author":"S Chen","year":"2020","unstructured":"Chen S, Manning C, van Tok M, Maeda Y, Montoro D, Kim J, et al. Interleukin-17D, a cytokine derived from stromal cells, attenuates joint inflammation [abstract]. Arthritis Rheum. 2020;72:supple10.","journal-title":"Arthritis Rheum"},{"key":"995_CR46","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41584-018-0044-2","volume":"14","author":"LS Taams","year":"2018","unstructured":"Taams LS, Steel KJA, Srenathan U, Burns LA, Kirkham BW. IL-17 in the immunopathogenesis of spondyloarthritis. Nat Rev Rheumatol. 2018;14:453\u201366.","journal-title":"Nat Rev Rheumatol"},{"key":"995_CR47","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.4049\/jimmunol.0801967","volume":"182","author":"S Zrioual","year":"2009","unstructured":"Zrioual S, Ecochard R, Tournadre A, Lenief V, Cazalis M-A, Miossec P. Genome-wide comparison between IL-17A- and IL-17F-induced effects in human rheumatoid arthritis synoviocytes. J Immunol. 2009;182:3112\u201320.","journal-title":"J Immunol"},{"key":"995_CR48","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1189\/jlb.3HI1215-542R","volume":"100","author":"T Noordenbos","year":"2016","unstructured":"Noordenbos T, Blijdorp I, Chen S, Stap J, Mul E, Ca\u00f1ete JD, et al. Human mast cells capture, store, and release bioactive, exogenous IL-17A. J Leukoc Biol. 2016;100:453\u201362.","journal-title":"J Leukoc Biol"},{"key":"995_CR49","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3389\/fimmu.2018.00795","volume":"9","author":"N Tamassia","year":"2018","unstructured":"Tamassia N, Arruda-Silva F, Calzetti F, et al. A reappraisal on the potential ability of human neutrophils to express and produce IL-17 family members in vitro: failure to reproducibly detect it. Front Immunol. 2018;9:795.","journal-title":"Front Immunol"},{"key":"995_CR50","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1007\/s00296-011-1995-7","volume":"32","author":"A Taylan","year":"2012","unstructured":"Taylan A, Sari I, Kozaci DL, Yuksel A, Bilge S, Yildiz Y, et al. Evaluation of the T helper 17 axis in ankylosing spondylitis. Rheumatol Int. 2012;32:2511\u20135.","journal-title":"Rheumatol Int"},{"key":"995_CR51","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10067-010-1647-4","volume":"30","author":"Y Mei","year":"2011","unstructured":"Mei Y, Pan F, Gao J, et al. Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis. Clin Rheumatol. 2011;30:269\u201373.","journal-title":"Clin Rheumatol"},{"key":"995_CR52","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1002\/art.23655","volume":"58","author":"C Jandus","year":"2008","unstructured":"Jandus C, Bioley G, Rivals J-P, Dudler J, Speiser D, Romero P. Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. Arthritis Rheum. 2008;58:2307\u201317.","journal-title":"Arthritis Rheum"},{"key":"995_CR53","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3892\/etm.2014.2046","volume":"9","author":"C Wang","year":"2015","unstructured":"Wang C, Liao Q, Hu Y, Zhong DA. T lymphocyte subset imbalances in patients contribute to ankylosing spondylitis. Exp Ther Med. 2015;9:250\u20136.","journal-title":"Exp Ther Med"},{"key":"995_CR54","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1093\/rheumatology\/key375","volume":"58","author":"J Braun","year":"2019","unstructured":"Braun J, Baraliakos X, Deodhar A, Poddubnyy D, Emery P, Delicha EM, et al. Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study. Rheumatology (Oxford). 2019;58:859\u201368.","journal-title":"Rheumatology (Oxford)"},{"key":"995_CR55","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13075-018-1582-3","volume":"20","author":"S Jo","year":"2018","unstructured":"Jo S, Wang SE, Lee YL, Kang S, Lee B, Han J, et al. IL-17A induces osteoblast differentiation by activating JAK2\/STAT3 in ankylosing spondylitis. Arthritis Res Ther. 2018;20:115.","journal-title":"Arthritis Res Ther"},{"key":"995_CR56","doi-asserted-by":"publisher","unstructured":"Shah M, Maroof A, Gikas P, Mittal G, Keen R, Baeten D, et al. Dual neutralisation of IL-17F and IL-17A with bimekizumab blocks inflammation-driven osteogenic differentiation of human periosteal cells. RMD Open. 2020. https:\/\/doi.org\/10.1136\/rmdopen-2020-001306.","DOI":"10.1136\/rmdopen-2020-001306"},{"key":"995_CR57","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/art.40770","volume":"71","author":"MN van Tok","year":"2019","unstructured":"van Tok MN, van Duivenvoorde LM, Kramer I, et al. Interleukin-17A inhibition diminishes inflammation and new bone formation in experimental spondyloarthritis. Arthritis Rheumatol (Hoboken NJ). 2019;71:612\u201325.","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"key":"995_CR58","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13075-016-0998-x","volume":"18","author":"AT Shaw","year":"2016","unstructured":"Shaw AT, Maeda Y, Gravallese EM. IL-17A deficiency promotes periosteal bone formation in a model of inflammatory arthritis. Arthritis Res Ther. 2016;18:104.","journal-title":"Arthritis Res Ther"},{"key":"995_CR59","doi-asserted-by":"publisher","first-page":"330ra37","DOI":"10.1126\/scitranslmed.aad8996","volume":"8","author":"\u00d6 Ulu\u00e7kan","year":"2016","unstructured":"Ulu\u00e7kan \u00d6, Jimenez M, Karbach S, et al. Chronic skin inflammation leads to bone loss by IL-17-mediated inhibition of Wnt signaling in osteoblasts. Sci Transl Med. 2016;8:330ra37.","journal-title":"Sci Transl Med"},{"key":"995_CR60","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41467-018-03124-z","volume":"9","author":"O Duchamp de Lageneste","year":"2018","unstructured":"Duchamp de Lageneste O, Julien A, Abou-Khalil R, Frangi G, Carvalho C, Cagnard N, et al. Periosteum contains skeletal stem cells with high bone regenerative potential controlled by Periostin. Nat Commun. 2018;9:773.","journal-title":"Nat Commun"},{"key":"995_CR61","first-page":"488","volume":"56","author":"AA El-Zayadi","year":"2017","unstructured":"El-Zayadi AA, Jones EA, Churchman SM, Baboolal TG, Cuthbert RJ, El-Jawhari JJ, et al. Interleukin-22 drives the proliferation, migration and osteogenic differentiation of mesenchymal stem cells: a novel cytokine that could contribute to new bone formation in spondyloarthropathies. Rheumatology (Oxford). 2017;56:488\u201393.","journal-title":"Rheumatology (Oxford)"},{"key":"995_CR62","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12974-015-0351-3","volume":"12","author":"IL McWilliams","year":"2015","unstructured":"McWilliams IL, Rajbhandari R, Nozell S, Benveniste E, Harrington LE. STAT4 controls GM-CSF production by both Th1 and Th17 cells during EAE. J Neuroinflammation. 2015;12:128.","journal-title":"J Neuroinflammation"},{"key":"995_CR63","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1038\/s41467-017-01771-2","volume":"8","author":"MH Al-Mossawi","year":"2017","unstructured":"Al-Mossawi MH, Chen L, Fang H, et al. Unique transcriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis. Nat Commun. 2017;8:1510.","journal-title":"Nat Commun"},{"key":"995_CR64","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41467-019-13853-4","volume":"11","author":"D Regan-Komito","year":"2020","unstructured":"Regan-Komito D, Swann JW, Demetriou P, Cohen ES, Horwood NJ, Sansom SN, et al. GM-CSF drives dysregulated hematopoietic stem cell activity and pathogenic extramedullary myelopoiesis in experimental spondyloarthritis. Nat Commun. 2020;11:155.","journal-title":"Nat Commun"},{"key":"995_CR65","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.cell.2015.11.009","volume":"163","author":"JT Gaublomme","year":"2015","unstructured":"Gaublomme JT, Yosef N, Lee Y, et al. Single-cell genomics unveils critical regulators of Th17 cell pathogenicity. Cell. 2015;163:1400\u201312.","journal-title":"Cell"},{"key":"995_CR66","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni.2416","volume":"13","author":"Y Lee","year":"2012","unstructured":"Lee Y, Awasthi A, Yosef N, et al. Induction and molecular signature of pathogenic TH17 cells. Nat Immunol. 2012;13:991\u20139.","journal-title":"Nat Immunol"},{"key":"995_CR67","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.jaci.2015.09.048","volume":"137","author":"J de Wit","year":"2016","unstructured":"de Wit J, Al-Mossawi MH, H\u00fchn MH, et al. ROR\u03b3t inhibitors suppress T(H)17 responses in inflammatory arthritis and inflammatory bowel disease. J Allergy Clin Immunol. 2016;137:960\u20133.","journal-title":"J Allergy Clin Immunol"},{"key":"995_CR68","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1007\/s10067-011-1843-x","volume":"30","author":"G-W Han","year":"2011","unstructured":"Han G-W, Zeng L-W, Liang C-X, Cheng B-L, Yu B-S, Li H-M, et al. Serum levels of IL-33 is increased in patients with ankylosing spondylitis. Clin Rheumatol. 2011;30:1583\u20138.","journal-title":"Clin Rheumatol"},{"key":"995_CR69","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1136\/ard.44.5.312","volume":"44","author":"AJ Freemont","year":"1985","unstructured":"Freemont AJ, Denton J. Disease distribution of synovial fluid mast cells and cytophagocytic mononuclear cells in inflammatory arthritis. Ann Rheum Dis. 1985;44:312\u20135.","journal-title":"Ann Rheum Dis"},{"key":"995_CR70","first-page":"supple10","volume":"72","author":"Z Stavre","year":"2020","unstructured":"Stavre Z, Bridgewood C, Zhou Q, Maeda Y, Karman J, McGonagle DGE. The role for neutrophils in the early phases of enthesitis in spondyloarthritis [abstract]. Arthritis Rheum. 2020;72:supple10.","journal-title":"Arthritis Rheum"},{"key":"995_CR71","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1136\/annrheumdis-2016-209454","volume":"76","author":"K De Wilde","year":"2017","unstructured":"De Wilde K, Martens A, Lambrecht S, et al. A20 inhibition of STAT1 expression in myeloid cells: a novel endogenous regulatory mechanism preventing development of enthesitis. Ann Rheum Dis. 2017;76:585\u201392.","journal-title":"Ann Rheum Dis"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-021-00995-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-021-00995-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-021-00995-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T10:58:45Z","timestamp":1667041125000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-021-00995-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,24]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["995"],"URL":"https:\/\/doi.org\/10.1007\/s11926-021-00995-y","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,24]]},"assertion":[{"value":"23 February 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"31"}}